Skip to main content

View full-text article in PMC

. 2019 Oct 16;14(10):e0223769. doi: 10.1371/journal.pone.0223769

Table 1. Medicines selected for survey.

Name	Medicine type	Dosage forms and strengths
Acarbose^*	OB	50 mg tab
	Generics	50 mg tab/cap
Glibenclamide^*	Generics	2.5 mg tab
Gliclazide^#	OB	30 mg SR tab, 80 mg tab
Gliclazide^#	Generics	30 mg SR tab, 80 mg tab
Glimepiride^*	OB	2 mg tab
	Generics	1 mg tab, 2 mg tab/cap
Glipizide^*	OB	5 mg CR tab
Glipizide^*	Generics	2.5 mg tab/cap, 5 mg tab/cap, 5 mg CR tab
Metformin^*	OB	500 mg tab, 800 mg tab
Metformin^*	Generics	250 mg tab/cap, 500 mg tab, 250 mg SR cap, 500 mg SR tab, 250 mg and 500 mg R cap/tab
Pioglitazone	OB	15 mg tab
Pioglitazone	Generics	5 mg tab, 15 mg tab/cap, 30 mg tab
Repaglinide	OB	1 mg tab, 2 mg tab
Repaglinide	Generics	0.5 mg tab, 1 mg tab, 2 mg tab

SR: sustained release; CR: controlled release; R: retard. OB: originator brands.

*: National essential medicine

^#: Provincial essential medicine